Elantas Beck India Ltd

Elantas Beck India, a midcap chemicals company, has faced notable stock volatility, with a recent decline of 7.91% on February 14, 2025. The stock has dropped 5.08% over two days and is trading below its moving averages, indicating ongoing challenges in the market compared to broader indices.

Elantas Beck India, a midcap chemicals company, experienced a notable gain on January 29, 2025, following a three-day decline. Despite today's positive movement, the stock remains below key moving averages and has seen a significant decline over the past month, contrasting with broader market trends.

Elantas Beck India, a midcap chemicals company, has seen its stock price decline significantly, dropping 6.09% on January 27, 2025, and a total of 10.03% over two days. The stock is underperforming compared to its sector and broader market indices, reflecting ongoing challenges.

Elantas Beck India, a midcap chemicals company, faced significant stock volatility on January 24, 2025, with a notable decline after an initial gain. The stock is trading below multiple moving averages and has dropped 16.96% over the past month, contrasting with the broader market's performance.

Elantas Beck India has seen a revision in its score following a significant decline in stock price, which underperformed the sector. The company, a midcap player in the chemicals industry, has been added to MarketsMOJO's list, reflecting ongoing challenges in its market performance and mixed trends in moving averages.

Elantas Beck India has undergone a revision in its score, reflecting recent market dynamics. Despite a decline in stock value, it managed to slightly outperform its sector. The company remains positioned above its 200-day moving average, indicating some resilience amid broader market challenges. It has also been added to MarketsMOJO's list, highlighting its ongoing evaluation in the financial landscape.

Elantas Beck India has recently experienced a revision in its score by MarketsMOJO, reflecting concerns over its long-term growth metrics and recent financial performance. Despite a solid return on equity and a history of outperforming the BSE 500 index, the stock's valuation remains high amid declining profits. The company has been added to MarketsMOJO's list, indicating a shift in market sentiment.

Elantas Beck India has experienced a revision in its score by MarketsMOJO, reflecting the company's mixed financial performance and market indicators. Despite a notable return over the past year and a stable financial structure, the stock faces challenges, including a recent decline in profits and modest sales growth.

Elantas Beck India, a leading chemical company in the midcap sector, saw a 5.5% increase in its stock price on November 14, 2024. Despite a 'Sell' call from MarketsMOJO, the stock showed a positive trend reversal and is currently trading higher than its long-term moving averages. It has also outperformed the Sensex in both short and long-term performance.

Elantas Beck India, a midcap chemical company, has been downgraded to a 'Sell' by MarketsMOJO due to its poor long-term growth and negative results in September 2024. The company's expensive valuation and recent decline in profits are also cause for concern. However, the company has a low debt to equity ratio and has consistently outperformed BSE 500 in the last 3 years. Investors should carefully consider their position in the stock.

On November 8th, 2024, Elantas Beck India's stock price fell by -5.17%, in line with the chemical sector's overall decline of -2.02%. Despite this, the stock has a 'Hold' call from MarketsMOJO and has been performing well in the long term. However, it has fallen below short term moving averages and touched an intraday low of Rs 13400. In comparison to the market, the stock has underperformed in the past month. This article presents factual information and does not include any external data or sources, providing a neutral and informative tone for readers interested in Elantas Beck India's performance in the chemical industry.

On October 30th, 2024, Elantas Beck India, a midcap chemical company, showed a positive performance with a 5.02% gain. It outperformed its sector by 3.16% and opened with a 5.09% gain. The stock is currently trading above its moving averages and has gained 11.66% in the past month, making it a stock to watch.

Elantas Beck India, a midcap chemical company, has reported a negative performance in the second quarter of fiscal year 2024-2025. The company's financial health has declined, with a decrease in key indicators such as PBT, PAT, PBDIT, and EPS. Investors are advised to consider these results before making any investment decisions.

Elantas Beck India, a leading chemical company in the midcap sector, has hit a 52-week high on October 14, 2024. The stock has shown consecutive gains for the last 9 days, with a 22.9% increase in returns. It is trading above its moving averages and has outperformed the Sensex, making it a potential long-term investment option.

Elantas Beck India, a leading midcap chemical company, has seen a surge in its stock price, hitting a 52-week high of Rs. 14495 on October 11, 2024. With a consistent 8-day winning streak and trading above its moving averages, the company's strong position in the market and impressive financial performance make it a promising investment opportunity.

Elantas Beck India, a leading chemical company in the midcap sector, has seen a significant rise in its stock price, reaching a 52-week high of Rs. 14493.95 on October 10th. The stock has been on a winning streak for the past 7 days, outperforming the sector by 0.4%. This, along with its strong financials and positive market sentiment, makes it a stock to watch out for in the midcap sector.

Elantas Beck India, a leading chemical company in the midcap sector, has reached a new milestone with its stock price hitting a 52-week high on October 9th, 2024. The stock has been on a steady rise, outperforming the sector and currently trading above its moving averages. With a 1-year performance of 80.52%, it is a promising investment opportunity.

Elantas Beck India, a leading chemical company in the midcap sector, has reached a new milestone with its stock price hitting a 52-week high on October 8th, 2024. The stock has been performing exceptionally well, outperforming the sector by 2.21% and gaining 17.08% in the last 5 days alone. This reflects the company's strong financials and growth potential, making it a promising stock for investors to consider.